Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Systems Biology | 7 | 2021 | 482 | 1.630 |
Why?
|
| Computational Biology | 13 | 2021 | 3505 | 1.040 |
Why?
|
| Models, Biological | 9 | 2018 | 9468 | 1.000 |
Why?
|
| Drug Repositioning | 4 | 2022 | 232 | 0.970 |
Why?
|
| Protein Interaction Mapping | 7 | 2021 | 617 | 0.910 |
Why?
|
| Abscisic Acid | 6 | 2013 | 41 | 0.800 |
Why?
|
| Nedocromil | 1 | 2019 | 46 | 0.690 |
Why?
|
| Models, Genetic | 7 | 2010 | 3442 | 0.660 |
Why?
|
| Budesonide | 1 | 2019 | 158 | 0.630 |
Why?
|
| Arabidopsis | 5 | 2014 | 464 | 0.620 |
Why?
|
| Haplotypes | 5 | 2007 | 2764 | 0.580 |
Why?
|
| Algorithms | 13 | 2022 | 13982 | 0.580 |
Why?
|
| Plant Growth Regulators | 3 | 2013 | 50 | 0.570 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 11902 | 0.510 |
Why?
|
| Placebo Effect | 1 | 2019 | 520 | 0.510 |
Why?
|
| Gene Regulatory Networks | 6 | 2021 | 1741 | 0.500 |
Why?
|
| Signal Transduction | 15 | 2021 | 23374 | 0.490 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 565 | 0.470 |
Why?
|
| Disease | 3 | 2021 | 671 | 0.470 |
Why?
|
| Plant Leaves | 2 | 2011 | 151 | 0.450 |
Why?
|
| Differential Threshold | 1 | 2013 | 80 | 0.430 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2019 | 788 | 0.400 |
Why?
|
| Programming, Linear | 2 | 2008 | 8 | 0.380 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 1792 | 0.380 |
Why?
|
| Computer Simulation | 10 | 2019 | 6218 | 0.360 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3106 | 0.290 |
Why?
|
| Arabidopsis Proteins | 3 | 2014 | 263 | 0.280 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2009 | 415 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2019 | 15790 | 0.260 |
Why?
|
| RNA, Untranslated | 1 | 2009 | 459 | 0.250 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2007 | 453 | 0.250 |
Why?
|
| Gene Expression Profiling | 5 | 2016 | 9406 | 0.230 |
Why?
|
| Oxidation-Reduction | 3 | 2021 | 2222 | 0.220 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3774 | 0.210 |
Why?
|
| Gene Expression Regulation, Plant | 3 | 2013 | 212 | 0.210 |
Why?
|
| Markov Chains | 1 | 2006 | 968 | 0.200 |
Why?
|
| Databases, Protein | 2 | 2018 | 388 | 0.190 |
Why?
|
| Sequence Alignment | 2 | 2005 | 2176 | 0.190 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 1754 | 0.190 |
Why?
|
| Nerve Net | 1 | 2013 | 2261 | 0.180 |
Why?
|
| Asthma | 1 | 2019 | 6172 | 0.180 |
Why?
|
| Leukemia, Large Granular Lymphocytic | 2 | 2011 | 24 | 0.180 |
Why?
|
| Fibrosis | 4 | 2021 | 2042 | 0.170 |
Why?
|
| Tryptophan | 1 | 2021 | 479 | 0.170 |
Why?
|
| Coronary Vessels | 2 | 2021 | 3112 | 0.170 |
Why?
|
| Transcription Factors | 4 | 2019 | 12102 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 2896 | 0.160 |
Why?
|
| Endophenotypes | 2 | 2021 | 255 | 0.160 |
Why?
|
| Energy Metabolism | 2 | 2021 | 2869 | 0.160 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 743 | 0.150 |
Why?
|
| Collagen Type III | 1 | 2018 | 91 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 2 | 2020 | 1091 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 2 | 2015 | 944 | 0.150 |
Why?
|
| Complement Activation | 1 | 2020 | 446 | 0.150 |
Why?
|
| Metabolome | 2 | 2015 | 982 | 0.150 |
Why?
|
| Vital Capacity | 1 | 2019 | 965 | 0.140 |
Why?
|
| Escherichia coli | 1 | 2009 | 4219 | 0.140 |
Why?
|
| Drug Interactions | 1 | 2021 | 1428 | 0.140 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 4626 | 0.140 |
Why?
|
| NADP | 1 | 2017 | 223 | 0.140 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4108 | 0.130 |
Why?
|
| Protein Binding | 5 | 2021 | 9335 | 0.130 |
Why?
|
| Drug Discovery | 3 | 2022 | 1057 | 0.130 |
Why?
|
| Cough | 1 | 2019 | 595 | 0.130 |
Why?
|
| Respiratory Sounds | 1 | 2019 | 697 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 11890 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2021 | 3094 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1078 | 0.120 |
Why?
|
| Models, Statistical | 2 | 2006 | 5075 | 0.120 |
Why?
|
| Endothelial Cells | 3 | 2021 | 3539 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1344 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4716 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7593 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2021 | 1804 | 0.110 |
Why?
|
| Digestive System Diseases | 1 | 2015 | 151 | 0.110 |
Why?
|
| NAD | 1 | 2017 | 609 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2013 | 102 | 0.110 |
Why?
|
| Interferon-gamma | 1 | 2021 | 3157 | 0.110 |
Why?
|
| Pulmonary Artery | 2 | 2018 | 1921 | 0.110 |
Why?
|
| Mathematical Computing | 1 | 2012 | 143 | 0.100 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 830 | 0.100 |
Why?
|
| Proteome | 2 | 2015 | 1855 | 0.100 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 15760 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 2 | 2020 | 1570 | 0.100 |
Why?
|
| Humans | 32 | 2022 | 760613 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 1311 | 0.100 |
Why?
|
| Calcinosis | 1 | 2020 | 1476 | 0.100 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2010 | 94 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2138 | 0.090 |
Why?
|
| Glucose | 1 | 2021 | 4350 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2020 | 4089 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2440 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4542 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 2543 | 0.070 |
Why?
|
| Plants | 1 | 2009 | 317 | 0.070 |
Why?
|
| Genome | 1 | 2015 | 1739 | 0.070 |
Why?
|
| Fungal Proteins | 2 | 2008 | 911 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 620 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 476 | 0.070 |
Why?
|
| Nonlinear Dynamics | 1 | 2009 | 494 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2022 | 4642 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2020 | 686 | 0.060 |
Why?
|
| Smad3 Protein | 2 | 2018 | 167 | 0.060 |
Why?
|
| Animals | 8 | 2021 | 167960 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2015 | 1915 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2014 | 3682 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2011 | 1765 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2006 | 385 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2012 | 2698 | 0.060 |
Why?
|
| Mutation | 3 | 2021 | 29957 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3226 | 0.060 |
Why?
|
| Melanoma | 1 | 2022 | 5697 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2009 | 1130 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2018 | 8022 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2018 | 3787 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 20080 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2011 | 2536 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2013 | 3562 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6065 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2021 | 18955 | 0.050 |
Why?
|
| Kynurenine | 1 | 2021 | 139 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 1996 | 0.050 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2021 | 128 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12628 | 0.040 |
Why?
|
| Complement Factor B | 1 | 2020 | 72 | 0.040 |
Why?
|
| Base Sequence | 1 | 2011 | 12444 | 0.040 |
Why?
|
| Complement C5 | 1 | 2020 | 106 | 0.040 |
Why?
|
| Genome, Human | 2 | 2021 | 4418 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5782 | 0.040 |
Why?
|
| Complement Pathway, Alternative | 1 | 2020 | 116 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 235 | 0.040 |
Why?
|
| Lung | 1 | 2018 | 9994 | 0.040 |
Why?
|
| Holistic Health | 1 | 2019 | 47 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2014 | 7850 | 0.040 |
Why?
|
| Ouabain | 1 | 2019 | 247 | 0.040 |
Why?
|
| Neoplasms | 2 | 2021 | 22075 | 0.040 |
Why?
|
| Binding Sites | 1 | 2007 | 6048 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 1 | 2018 | 178 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2021 | 488 | 0.040 |
Why?
|
| Complement C3 | 1 | 2020 | 451 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2006 | 2326 | 0.040 |
Why?
|
| Carbamazepine | 1 | 2018 | 224 | 0.040 |
Why?
|
| Phylogeny | 1 | 2005 | 2775 | 0.040 |
Why?
|
| Glycolysis | 1 | 2021 | 828 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2007 | 5434 | 0.040 |
Why?
|
| Proteins | 1 | 2012 | 6029 | 0.040 |
Why?
|
| Arginine | 1 | 2021 | 934 | 0.040 |
Why?
|
| Serine | 1 | 2021 | 831 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2020 | 859 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10826 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2017 | 197 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 886 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2011 | 12762 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2017 | 564 | 0.030 |
Why?
|
| Inflammation | 3 | 2020 | 10755 | 0.030 |
Why?
|
| Models, Animal | 1 | 2021 | 2117 | 0.030 |
Why?
|
| Alleles | 1 | 2006 | 6900 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1242 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10442 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2018 | 427 | 0.030 |
Why?
|
| Thrombosis | 2 | 2020 | 3051 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2020 | 1485 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 1809 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2014 | 458 | 0.030 |
Why?
|
| Phenotype | 2 | 2021 | 16548 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64981 | 0.030 |
Why?
|
| Rats | 2 | 2020 | 23709 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 1173 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2011 | 145 | 0.020 |
Why?
|
| Child | 1 | 2019 | 79799 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15286 | 0.020 |
Why?
|
| Male | 5 | 2021 | 359718 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2016 | 532 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2012 | 354 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 939 | 0.020 |
Why?
|
| Propensity Score | 1 | 2018 | 1926 | 0.020 |
Why?
|
| Histones | 1 | 2021 | 2582 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2021 | 2519 | 0.020 |
Why?
|
| Female | 5 | 2021 | 391246 | 0.020 |
Why?
|
| Genes, Plant | 1 | 2010 | 128 | 0.020 |
Why?
|
| Exercise Test | 1 | 2018 | 2128 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 2255 | 0.020 |
Why?
|
| Cell Movement | 1 | 2021 | 5206 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5201 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 29661 | 0.020 |
Why?
|
| Hyperuricemia | 1 | 2011 | 225 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7587 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2803 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8158 | 0.020 |
Why?
|
| Yeasts | 1 | 2008 | 279 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3306 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1398 | 0.020 |
Why?
|
| Heart Failure | 2 | 2021 | 11848 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3800 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14374 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 10181 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12531 | 0.010 |
Why?
|
| Mice | 2 | 2021 | 81209 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22052 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3817 | 0.010 |
Why?
|
| Cell Survival | 1 | 2011 | 5797 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11481 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 1483 | 0.010 |
Why?
|
| Middle Aged | 3 | 2021 | 220359 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18137 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15840 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2011 | 8311 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 6659 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41337 | 0.010 |
Why?
|
| Hospitalization | 1 | 2018 | 10789 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 24102 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 169143 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13262 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 12957 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 74333 | 0.010 |
Why?
|
Concepts
(215)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(36)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_